CTSI

Pittsburgh, United States Founded: 2006 • Age: 20 yrs Acquired By Varian Medical Systems
Clinical and administrative solutions for cancer treatment are provided.
Annual revenue - Latest available
Total funding $2.0M 1 rounds
Employees 5 Tracked headcount
Investors 2 Known backers
Products - Services tracked
Competitors - Brand Intelligence

About CTSI

CTSI is a company based in Pittsburgh (United States) founded in 2006 by Peter Ellis and Stanley Marks was acquired by Varian Medical Systems in May 2019. CTSI has raised $2 million across 1 funding round from investors including Varian and TPG. The company has 5 employees as of December 31, 2017.

  • Headquarter Pittsburgh, United States
  • Employees 5 as on 31 Dec, 2017
  • Founders Peter Ellis, Stanley Marks
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
Operational Areas
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $2 M (USD)

    in 1 rounds

  • Latest Funding Round
    $2 M (USD), Seed

    Mar 16, 2009

  • Investors
    Varian

    & 1 more

  • Employee Count
    5

    as on Dec 31, 2017

  • Acquired by
    Varian Medical Systems

    & 1 more

    (May 20, 2019)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of CTSI

CTSI has successfully raised a total of $2M through 1 strategic funding round. The most recent funding activity was a Seed round of $2 million completed in March 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Seed — $2.0M
  • First Round

    (16 Mar 2009)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2009 Amount Seed - CTSI Valuation

investors

Investors in CTSI

CTSI has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Varian and TPG.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Fund of funds focused on pre-seed and seed-stage companies
Founded Year Domain Location
Varian is focused on developing cancer treatment technologies.
Founded Year Domain Location

Investments & Acquisitions by CTSI

Investments

Financial Statements - CTSI

Ctsi Comparisons

+
Add Comparison
Available on Premium

Competitors of CTSI

Latest news on Ctsi

Frequently Asked Questions about CTSI

CTSI was founded in 2006 and raised its 1st funding round 3 years after it was founded.

CTSI is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.

CTSI is a funded company, having raised a total of $2M across 1 funding round to date. The company's 1st funding round was a Seed of $2M, raised on Mar 16, 2009.

As of Dec 31, 2017, the latest employee count at CTSI is 5.

CTSI was founded in 2006 in Pittsburgh, United States, within the healthcare sector focused on oncology. A network of cancer treatment facilities has been established, including the flagship American Oncology Institute. Services offered encompass radiation oncology, medical oncology, surgical oncology, diagnostics, and support care for complex diseases. Operations are centered on clinical and administrative solutions to support treatment processes.

CTSI has 2 investors. Key investors include Varian, and TPG.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available